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Background There is an increasing body of evidence from trials suggesting that
major reductions in neonatal mortality are possible through
community-based interventions. Since these trials involve packages
of varying content, determining how much of the observed mortal-
ity reduction is due to specific interventions is problematic. The
Lives Saved Tool (LiST) is designed to facilitate programmatic prior-
itization by modelling mortality reductions related to increasing
coverage of specific interventions which may be combined into
packages.
Methods To assess the validity of LiST outputs, we compared predictions
generated by LiST with observed neonatal mortality reductions in
trials of packages which met inclusion criteria but were not used as
evidence inputs for LiST.
Results Four trials, all from South Asia, met the inclusion criteria. The
neonatal mortality rate (NMR) predicted by LiST matched the
observed rate very closely in two effectiveness-type trials. LiST pre-
dicted NMR reduction was close (absolute difference <5/1000 live
births) in a third study. The NMR at the end of the fourth study
(Shivgarh, India) was overestimated by 39% or 16/1000 live births.
Conclusions These results suggest that LiST is a reasonably reliable tool for use
by policymakers to prioritize interventions to reduce neonatal
deaths, at least in South Asia and where empirical data are unavail-
able. Reasons for the underestimated reduction in one trial likely
include the inability of LiST to model all effective interventions.
Keywords child survival, neonatal mortality, modelling, Lives Saved Tool,
Bangladesh, India, Pakistan
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Introduction
Each year almost 4 million neonatal deaths (first
28 days of life) occur, accounting for an estimated
41% of all under-5 deaths.1,2 There is increasing
policy and programme attention to reducing neonatal
deaths, which have previously been relatively
neglected in both maternal and child health
programmes. Given limited funding and the short
time to the Millennium Development Goal deadline
of 2015, the imperative to invest in the most effective
interventions is clear. However, a ‘one size fits all’
approach is unlikely to work since the effect of inter-
ventions will depend on the local cause-of-death
profile and the health system platforms available
for scale up.3 Decision-makers require information
on the likely impacts of different interventions in
their own setting, together with information on the
incremental cost of adding interventions to an exist-
ing package either at facility or community level.
The Lives Saved Tool (LiST) has been designed
for the purpose of facilitating programmatic decisions
based on mortality effects. LiST allows users to model
the estimated impact of scaling up a specific mater-
nal, newborn and child health intervention by
increasing the coverage for a defined population
which may be one country, state or district. An
important feature of LiST is that it models explicitly
the effects of changes in individual-level interventions
such as exclusive breastfeeding of a newborn or
ORS treatment of a child with diarrhoea. The pub-
lic health strategies by which coverage of these inter-
ventions is increased (e.g. peer counselling,
community mobilization, etc.) are not modelled expli-
citly in LiST. It is up to the user to decide what levels
of coverage can be achieved with the strategies and
resources at their disposal. LiST is built into the
widely accepted demographic software package
‘Spectrum’, designed to model population changes
over time by age and sex4,5 and includes recent mor-
tality rates by country with neonatal and under-5
cause-of-death estimates. The neonatal cause-of-death
estimates are based on methods published previously,6
but have been updated for the year 2004 and cleared by
WHO with countries.7,8 The neonatal mortality module
in LiST is based upon evidence-based reviews for
intervention impact originally undertaken for The
Lancet Neonatal series.9 A standard methodology has
been developed by the Child Health Epidemiology
Reference Group (CHERG)10 for systematic review,
rating of the evidence and estimation of mortality
effect using an adapted GRADE methodology.
Reviews of individual interventions are presented
elsewhere in this supplement.11–15
Objective
To assess the validity of LiST for modelling
neonatal mortality by comparing the reductions in
neonatal mortality predicted by LiST with observed
changes in mortality in field trials of packages of
interventions.
Methods
Model
The development of LiST and the modelling assump-
tions that it makes are described in detail in several
articles in this supplement. Briefly, LiST is a cohort
model of neonatal and child survival, up to 5 years
of age, embedded within the Spectrum Policy
Modelling System (http://www.futuresinstitute.org).
It provides estimates of the effects on cause-specific
mortality (e.g. on deaths and mortality rates) of chan-
ging the coverage of different interventions. Several
interventions in the model affect specific causes of
neonatal death and thus neonatal mortality rates.
The current effect sizes that LiST assumes for each
intervention and each cause of neonatal death
(except diarrhoea and congenital anomalies) are
shown in Table 1.
Analysis
Validation data were selected based on the following
inclusion criteria:
(i) Published studies with neonatal mortality data
at baseline and endline, including cause-
specific data or data from a similar population
that could be used for the cause-of-death
profile.
(ii) Coverage data at baseline and endline for indi-
cators to allow at least two interventions to be
modelled.
(iii) The study results had not been used as inputs
to the effect estimates in the model.
Four studies met the inclusion criteria (Table 2).16–22
One was an effectiveness trial (Hala)16 whereas
another simulated near program conditions
(Sylhet).17,22 In the remaining two studies, the
research team played an important role in assuring
the delivery of the intervention package. In the inter-
vention areas, packages of interventions designed to
affect neonatal mortality were delivered. Only the pri-
mary intervention area was modelled for each study.
Neonatal researchers involved in these studies or
other studies of neonatal interventions (ZB, GD and
JL) met to map the coverage indicators of the inter-
ventions which were implemented and/or measured
in each study onto the coverage indicators included
in LiST. For each study, there was extensive discus-
sion about which indicators were the most appropri-
ate (Table 3). For components of facility delivery,
such as comprehensive emergency obstetric care,
basic emergency obstetric care, neonatal resuscitation,
antenatal corticosteroids and antibiotics for preterm
prolonged rupture of membranes, coverage data
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were not available. Thus, based on previous reviews
by the Lancet Neonatal Series team, a standard pro-
portion of women who deliver at a facility were
assumed to receive each of the components.9 See
the Supplementary appendix for the relevant frac-
tions. The final mapping of the study indicators
onto LiST indicators was performed prior to running
the model and seeing the results. Study indicators
which could not be mapped within LiST are shown
in Table 4. For each study, a LiST model of the study
population at baseline was created, including total
population, fertility trends, health status (including
nutritional status), neonatal mortality rates and
cause-specific proportions of neonatal deaths
(cause-of-death profile).
Each study was then modelled in LiST to determine
the predicted change in neonatal mortality given the
changes in intervention coverage observed in the
study. The changes in mortality predicted by
the model were then compared with the changes
actually observed in each study. The specific mod-
elling details for each study, including non-
standard-coding methods are described below. All
modelled interventions are described in Table 5.
Description of studies used for validation
and modelling assumptions
Sylhet, Bangladesh17,22
The home-care arm of the study was modelled. The
neonatal mortality rate measured in the trial
Table 1 Cause-specific percent reduction in mortality estimated for interventions in LiST which affect neonatal mortality
LiST interventions
Neonatal
sepsis,
meningitis
and
pneumonia
Preterm
birth
complications
Birth
asphyxia
Neonatal
tetanus
Other
unspecified
neonatal
causes of
death
Syphilis detection and treatment 2.5%
TT immunization 94
Multiple micronutrient supplementation  
Antibiotics for women with preterm pro-
longed rupture of membranes to delay
birth and reduce associated infection
risk
8 12
Antenatal corticosteroids for women with
anticipated preterm labour (to reduce
risk/severity of respiratory complications
of premature birth)
53
Skilled attendance and simple immediate
newborn care
25 10 25 36
Basic emergency obstetric care including
simple immediate newborn care
25 10 40 36
Comprehensive emergency obstetric care
including simple immediate newborn
care
25 10 80 36
Neonatal resuscitation (facility) 10 30
Neonatal resuscitation (home) 5 20
Clean delivery (home) 20 30
Kangaroo mother care (facility only) 51
Preventive postnatal care 31 35
Breastfeeding promotion y
Oral antibiotic case management of
neonatal infections
42
Injectable antibiotic case management of
neonatal infections
68
Full supportive care for serious neonatal
illness
83 28 5 10
Excluded are folic acid for congenital anomalies and oral rehydration salt solution for diarrhoea.
Multiple micronutrient supplementation (iron, folateþ a third nutrient) reduces IUGR and thus the probability of dying from
infections and birth asphyxia.26,27
yBreastfeeding acts as a risk factor preventing neonatal diarrhoea and neonatal sepsis, meningitis and pneumonia deaths.26
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population at baseline was used together with the
study-specific cause-of-death profile. The Bangladesh
national fertility trends in Spectrum were used with-
out additional adjustment. For antenatal care (ANC),
the coverage indicator used was one or more visits
during pregnancy, although the ideal LiST indicator
is four or more visits. Within LiST, ANC is only
linked to the intervention of syphilis detection and
treatment. As this was not measured in the trial, it
was calculated based upon standard formulas built
into LiST under the assumption that a given
proportion women would have received this when
visiting providers for routine ANC.9 For tetanus
toxoid (TT) immunization, the coverage indicator
used was two doses of TT during pregnancy. For mul-
tiple micronutrient supplementation, maternal report
of taking an iron-containing compound during preg-
nancy was the coverage indicator used. The available
indicator of facility birth was used and linked to
selected facility-based interventions (antenatal corti-
costeroids for women with anticipated preterm
labour, antibiotics for preterm prolonged rupture of
Table 3 Baseline and endline coverage estimates (%) used in the LiST modelling
Sylhet17 SEARCH19,20,a Hala16 Shivgarh21
LiST Interventions
Baseline
(%)
Endline
(%)
Baseline
(%)
Endline
(%)
Baseline
(%)
Endline
(%)
Baseline
(%)
Endline
(%)
Syphilis detection and
treatmentb
9.7 14.4 9.0 39.0 11.2 56.0 0.3 2.6
TT immunization 39.6 39.1 79.0 95.7 65.0 78.5 93.9 94.4
Multiple micronutrient
supplementation
42.5 83.7 c
Antibiotics for women with
preterm prolonged rupture
of membranes to delay
birth and reduce associated
infection riskd
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Antenatal corticosteroids for
women with anticipated
preterm labour (to reduce
risk/severity of respiratory
complications of premature
birth)
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Skilled attendance and simple
immediate newborn cared
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Basic emergency obstetric
care and simple immediate
newborn cared
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Comprehensive emergency
obstetric care and simple
immediate newborn cared
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Neonatal resuscitation
(facility)d
7.0 14.1 5.1 4.1 46.8 67.0 7.9 19.7
Clean delivery (home)e 2.8 72.3 96.7 94.7 49.0 68.9 6.0 47.2
Neonatal resuscitation
(home)
0 82.6
Preventive postnatal care 0 72.0 0 81.0 44.6 88.0 0.9 84.9
Breastfeeding promotion 0 97.0 0 81.0 0 68.0
Utilization of Injectable
antibiotic case management
of serious neonatal illness
0 41.5 0 93.3
Full supportive care for
serious neonatal illness
0 31.9
aAdditional data from personal communication.
bA function of antenatal care coverage.
cAll blank cells indicated that no coverage change was modelled.
dA function of facility delivery coverage. See Supplementary appendix for translation formula.
ePercents refer to percent of home deliveries.
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membranes (pPRoM), basic emergency obstetric care,
comprehensive emergency obstetric care and neonatal
resuscitation) using standard formulas built into
LiST. Clean delivery at home was defined as use of
a clean delivery kit or a boiled cutting instrument at
delivery and based on trial data. In the home-care
arm of the study, case management of serious neo-
natal illness included successful referral to a facility,
or if referral was not successful, provision of inject-
able antibiotics in the community. Of the children
who were identified to have a serious neonatal illness,
31.9% were successfully referred (and modelled as full
supportive care for serious neonatal illness) and an
additional 41.5% received injectable antibiotics in the
community (and modelled as ‘injectable antibiotics
for case management of serious neonatal illness’).
Data were unavailable for the type of treatment
received at health facilities by the referred patients.
SEARCH, India19,20
The fertility trends were based on the Maharashtra
population data in the National Family Health
Survey23 and matched the crude birth rates observed
in the intervention area. The cause-of-death data used
were modified from Bang et al.19 by the investigator to
fit the CHERG Neonatal group standard hierarchy,
with some early infection deaths in very preterm
infants being reclassified to the category of preterm
as a direct cause of death. Village health workers vis-
ited homes during pregnancy to promote breastfeed-
ing, and also visited the home within 24 h after
delivery. The coverage of these home visits was used
as the indicator for both preventive postnatal care and
breastfeeding promotion. Coverage of neonatal resus-
citation in the home was based on the percentage of
births with a village health worker present at birth,
since all study health workers were trained in resus-
citation. Most sepsis cases were treated in the
community using a combination of injectable and
oral antibiotics. This was modelled as ‘injectable
antibiotics for case management of serious neonatal
illness’.
Hala, Pakistan16
Pakistani national data regarding cause-specific neo-
natal mortality were used,24 as were standard
national fertility trends from Spectrum. Coverage of
one or more antenatal visits was used for ANC and
linked interventions. Data for coverage of two doses
of TT immunization were collected in the study sur-
veys, as was skilled birth attendance. For the indica-
tor of clean home birth, the coverage with lady health
workers at home for birth was used. Early initiation
of breastfeeding was the indicator used for breast-
feeding promotion.
Shivgarh, India21
The fertility trends used were based on the rural Uttar
Pradesh population data in the National Family
Health Survey.25 In this trial, mortality was measured
both through household surveys and prospectively by
a demographic surveillance system. As surveys may
underestimate mortality, we used only surveillance
data and used the observed mortality rate at endline
in the comparison arm as the proxy for the baseline
mortality rate in the intervention arm. The third arm
of the study, (intervention package plus Thermospot),
was excluded from the analysis as we chose only one
arm to evaluate for each study and it would be diffi-
cult to model the additional impact of the
ThermoSpot within LiST. However, intervention cov-
erage figures and mortality impact in the two arms
were not significantly different. Since neonatal
cause-of-death data were not yet available from the
study or from the state of Uttar Pradesh, the baseline
cause of death profile used was the same as the
SEARCH study, which is from a similar context in
rural India. The indicator used in LiST for ANC and
linked interventions was one or more ANC visits from
the trial data as the ideal indicator of four or more
routine ANC visits was not reported. Data were avail-
able for the coverage of two doses of TT vaccine.
‘Delivery into hands’ instead of on the ground was
the indicator used for a clean home delivery.
Although several thermal care indicators were
reported, the most important one was considered to
Table 4 Interventions or indicators which could not be
mapped to LiST, by study
Study Intervention/Educational item
Sylhet Breastfeeding initiated within 1 h of delivery
First bath delayed until the third day
Promotion of early care seeking for ill
neonates
SEARCH Community mobilization and birth
preparedness, e.g. mothers and
grandmothers
Injection of Vitamin K
Treatment of superficial infections
Community care of preterm/LBW infants
Hala Early initiation of breast feeding
Delayed bathing
Clean cord care
Promotion of early care seeking for ill neo-
nates and mother
Shivgarh Breastfeeding initiated within 1 h of delivery
Thermal care, e.g. drying at birth, delayed
bathing within 24 h
Cut umbilical cord with a clean blade
Community mobilization and birth
preparedness
Promotion of early care seeking for ill
neonates
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be skin-to-skin care within 24 h of birth. This was
used as the indicator for appropriate preventive post-
natal care. Similar to the Hala study, early initiation
of breastfeeding was the indicator used for breast-
feeding promotion.
Results
More than 40 interventions were included in the ver-
sion of LiST used at the time of this analysis (version
4.0, which is not publically available at the time of
writing). Of these, 19 have an effect on neonatal mor-
tality (Table 1). For each study included in the vali-
dation exercise, all the coverage indicators that were
available were mapped to interventions in the LiST
model (Table 5). For each of the studies, several indi-
cators or interventions were not able to be mapped to
the model (Table 4).
Model outputs and observed mortality reductions
are presented in Table 6. For three of the four studies,
the modelled effect of the interventions closely
matched the observed study results, with the pre-
dicted impact lying within the confidence bounds
for the observed results. The one outlier was the
Shivgarh trial. In this study, control area mortality
(used as a proxy for baseline mortality in the model-
ling) was extremely high (84 per 1000 live births) and
a very large reduction (58%) to 41 per 1000 live
births was observed in the intervention area. In this
study, LiST overestimated the observed NMR at the
end of the study by 39%. Across the Hala, Sylhet,
SEARCH and Shivgarh studies, the estimates derived
using LiST differed from the observed rates of neona-
tal mortality by 0, 2, 5 or 16 per 1000 live births,
respectively.
Discussion
This is the first attempt to validate the modelling of
neonatal lives saved which has been developed over
the past 5 years and is now incorporated within LiST.
NMRs predicted by LiST were remarkably close to
those observed in three out of the four studies used
for validation. For the two studies implemented under
routine (or close to routine) programme conditions,
the model predictions were almost identical to the
observed results (Hala, Pakistan16 and Sylhet,
Bangladesh17). For the two studies which were
closer to efficacy-type studies, the mortality reduc-
tions observed were greater than those predicted by
LiST: i.e. LiST appears to produce conservative esti-
mates of the mortality effect. This is a reassuring find-
ing for a tool that aims to model programme
effectiveness. These results suggest that LiST is a rea-
sonably reliable tool for use by policymakers to prior-
itize interventions for maximal effect on neonatal
deaths, at least in South Asia.
There are a number of possible explanations for the
underestimation of the neonatal mortality effect by
LiST in these trials. The first is that these were
efficacy-type trials and set in populations with espe-
cially high mortality, suggesting that the model is
conservative, as per the stated objective of including
effectiveness estimates in the model. In addition, this
model only includes interventions which have an
evidence-based, cause-specific effect on mortality
and are included in LiST. Thus, interventions which
are likely to have an effect, but for which insufficient
high-quality data have been collected to adequately
generate a valid effect size were excluded from the
modelling exercise, such as thermal care improve-
ments or early initiation of breastfeeding. Another
possible explanation for the conservative nature of
the model is that some interventions may have a
synergistic effect when delivered together that is dif-
ficult to quantify. Finally, in all environments, there
are always changes which cannot be quantified, such
as quality changes when intensive implementation
has occurred, or on which data have not been col-
lected. However, this should not be taken to mean
that these changes have no effect. This also applies
to non-health or distal factors that we are unable to
Table 6 Neonatal mortality rates for four validation studies, measured at baseline, measured at endline (or concurrent
control), and modelled for endline using LiST
Baseline
(or control) Endline
Observed
mortality
reduction Endline Absolute Relative
NMR Measured NMR Difference Modelled NMR Differencea
Differenceb
(%)
Study (95% CI) (95% CI) (%)
Sylhet 47 (26–68) 29 (20–39) 18 (38) 31 2/1000 þ7
SEARCH 62 (51–73) 26 (16–36) 36 (58) 31 5/1000 þ19
Hala 57 (48–66) 41 (34–48) 16 (28) 41 0/1000 0
Shivgarh 84 (66–102) 41 (30–52) 43 (51) 57 16/1000 þ39
95% CI: Sylhet: Ahmed, personal communication; Hala: Bhutta, personal communication; Shivgarh: Kumar, personal communi-
cation; SEARCH, Bang, personal communication.
aPredicted NMR—observed NMR.
bPercent difference between measured and modelled endline NMR.
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model in LiST such as changes in education, women’s
empowerment, food availability, and other factors
which are known to affect overall mortality rates
but do not have a clear cause-specific effect that can
be modelled over and above their impact on coverage
changes.
Only in one study did the observed mortality
reduction differ by more than five neonatal deaths
per 1000 live births. In this trial, in Shivgarh,21 a
more comprehensive set of behaviour change
interventions were implemented, including monthly
community and folk song meetings with behaviour
change messages, birth preparedness and education
of a variety of newborn care stakeholders. More of
the study activities and indicators could not be
mapped in LiST than in the other trials. Perhaps
more importantly, this study did not have measured
neonatal mortality at baseline in the modelled arm of
the trial; rather, the concurrent control area neonatal
mortality rate was used as a proxy for the baseline
rate. In addition, this area’s neonatal mortality
rate was extremely high. Also, the use of a
cause-of-death profile from another site introduced
additional uncertainty. Thus, it was expected that
the model would underestimate the neonatal
mortality reduction.
Although the results of this validation exercise are
encouraging, it should be noted that all four studies
were performed in South Asia. A similar validation to
compare LiST estimates of mortality reduction with
study results from Africa, East Asia or South or
Central America would be helpful, but unfortunately
no published studies from these regions met our
inclusion criteria. However, there are neonatal out-
come studies now in progress in these regions so
such comparative analysis may soon be possible. It
would also be of interest to perform additional vali-
dations with nationally representative databases such
as in the Demographic and Health (DHS) and
Multiple Indicator Cluster (MIC) surveys, for exam-
ple, similar to that presented by Hazel and Bhutta.27
in this journal issue, using the default CHERG
cause-of-death profiles.
In summary, LiST appears to model well the effect of
interventions on neonatal mortality. One limitation of
LiST is in the number and variety of interventions
included in the model for which high quality empir-
ical coverage data are also available. Given the rela-
tively recent attention to reducing neonatal mortality,
the comparability and availability of coverage indica-
tors is an important area to advance within large scale
surveys, health facility assessments and in pro-
grammes and research. Although further validation
of the model is desirable, the results obtained here
suggest that LiST can be used as a reasonable guide
for decision making when adequate data are unavail-
able or to extrapolate to future outcomes for lives
saved with given changes in coverage. Important
gaps remain in the evidence for neonatal mortality
reduction, with ironically more rigorous evidence
now available from community level than from facil-
ity level. In addition, important changes in commu-
nity interactions and behaviour change remain
challenging to model, but may be especially important
in high mortality settings, such as Shivgarh, where
almost 10% of babies die, many of whom are term
babies with preventable and treatable problems. In
addition, important changes in community interac-
tions and behaviour change remain challenging to
model, but may be especially important in high mor-
tality settings, such as the study from Shivgarh,
where currently almost 10% of babies die, many of
whom are term babies dying from preventable and
treatable conditions.
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Supplementary data are available at IJE online.
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KEY MESSAGES
 The LiST modelled results matched well with the observed results of 4 published community trials of
neonatal interventions in South Asia.
 LiST can aid in program planning by modelling the potential impacts of community-based neonatal
interventions, although more validation is needed, especially in African contexts.
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